Epoetin beta

Jump to: navigation, search
Epoetin beta
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Epoetin beta

Articles

Most recent articles on Epoetin beta

Most cited articles on Epoetin beta

Review articles on Epoetin beta

Articles on Epoetin beta in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Epoetin beta

Images of Epoetin beta

Photos of Epoetin beta

Podcasts & MP3s on Epoetin beta

Videos on Epoetin beta

Evidence Based Medicine

Cochrane Collaboration on Epoetin beta

Bandolier on Epoetin beta

TRIP on Epoetin beta

Clinical Trials

Ongoing Trials on Epoetin beta at Clinical Trials.gov

Trial results on Epoetin beta

Clinical Trials on Epoetin beta at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Epoetin beta

NICE Guidance on Epoetin beta

NHS PRODIGY Guidance

FDA on Epoetin beta

CDC on Epoetin beta

Books

Books on Epoetin beta

News

Epoetin beta in the news

Be alerted to news on Epoetin beta

News trends on Epoetin beta

Commentary

Blogs on Epoetin beta

Definitions

Definitions of Epoetin beta

Patient Resources / Community

Patient resources on Epoetin beta

Discussion groups on Epoetin beta

Patient Handouts on Epoetin beta

Directions to Hospitals Treating Epoetin beta

Risk calculators and risk factors for Epoetin beta

Healthcare Provider Resources

Symptoms of Epoetin beta

Causes & Risk Factors for Epoetin beta

Diagnostic studies for Epoetin beta

Treatment of Epoetin beta

Continuing Medical Education (CME)

CME Programs on Epoetin beta

International

Epoetin beta en Espanol

Epoetin beta en Francais

Business

Epoetin beta in the Marketplace

Patents on Epoetin beta

Experimental / Informatics

List of terms related to Epoetin beta

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Epoetin beta (rINN) (pronounced /ɛˈpoʊɨtɨn/) is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

Epoetin is marketed under the trade names NeoRecormon.[2] It is only sold in Europe.

References

  1. Dunn CJ, Markham A (1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs. 51 (2): 299–318. PMID 8808169.
  2. Amgen - Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.

External links



Linked-in.jpg